Deciphering the response and resistance to immunecheckpoint inhibitors in lung cancer with artificial intelligence-based analysis: the pioneer and quantic joint-projects - Inria - Institut national de recherche en sciences et technologies du numérique Access content directly
Journal Articles British Journal of Cancer Year : 2020

Deciphering the response and resistance to immunecheckpoint inhibitors in lung cancer with artificial intelligence-based analysis: the pioneer and quantic joint-projects

Abstract

Despite striking results, clinical outcome with immune checkpoint inhibitors remains too often uncertain. This joint-project aims at generating dense longitudinal data in lung cancer patients undergoing anti-PD1 or anti-PDL1 therapy, alone or in combination with other anticancer agents. Mathematical modelling with mechanistic learning algorithms will be used next to decipher the mechanisms underlying response or resistance to immunotherapy. Ultimately, this project should help to better understand the mechanisms underlying resistance to immune checkpoint inhibitors and identify a serial of actionable items to increase the efficacy of immunotherapy.
Fichier principal
Vignette du fichier
Main text BJC comment ciccolini final.pdf (291.52 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03147110 , version 1 (19-02-2021)

Identifiers

Cite

Joseph Ciccolini, Sébastien Benzekry, Fabrice Barlesi. Deciphering the response and resistance to immunecheckpoint inhibitors in lung cancer with artificial intelligence-based analysis: the pioneer and quantic joint-projects. British Journal of Cancer, 2020, 123 (3), pp.337-338. ⟨10.1038/s41416-020-0918-3⟩. ⟨hal-03147110⟩
100 View
167 Download

Altmetric

Share

Gmail Facebook X LinkedIn More